论文信息 - A phase I trial with extended cohort of gemcitabine and vinorelbine followed by autologous peripheral blood stem cell transplantation for recurrent or refractory Hodgkin’s lymphoma

A phase I trial with extended cohort of gemcitabine and vinorelbine followed by autologous peripheral blood stem cell transplantation for recurrent or refractory Hodgkin’s lymphoma

6651 Background: High dose chemotherapy and autologous stem cell transplantation (ASCT) is the most effective treatment for recurrent or refractory Hodgkin’s lymphoma (HL). Disease recurrence is st...